online glp-1 agonist weight loss services Injections: Semaglutide and Tirzepatide GLP-1s for Weight Loss -

Comparative analysis of cancer risk among glucose-lowering agents Current clinical evidence indicates that various classes of antidiabetic drugs show substantial variability in their association with cancer risk

Mitchell JL, Lyons HS, Walker JK, et al

If ingesting the pill cannot be avoided, a general recommendation is to drink about 100 mL of water immediately after taking the pill and to avoid a recumbent position for a few minutes after swallowing

Patients education about these risks and discontinuation of the drug if concerning symptoms for thyroid carcinoma (neck mass, hoarseness of the voice, difficulty swallowing or breathing) develop is mandatory

Currently, GLP-1 receptor agonist products on the market are all injectable forms

2024;16(8):e66500